Sichenzia Ross Ference Carmel represented INmune Bio, Inc. in the offering.INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company, announced approximately $4.8 million registered direct offering…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Leila Ahmed
…
This content is for Standard 1 Year members only. LoginJoin Now